人T淋巴细胞白血病不同细胞株的混合抗原肽诱导特异性CTLs细胞毒效应及其交叉反应性分析  

Specific anti-tumor immunity and its cross-reaction induced by antigen peptide mixture prepared from different T lymphocytic leukaemia cell lines

作　　者：黄波[1] 冯作化[1] 李东[1] 张桂梅[1] 王洪涛[1] 

机构地区：[1]华中科技大学同济医学院医学分子生物学研究室,武汉430030

出　　处：《中华肿瘤杂志》2003年第1期9-12,共4页Chinese Journal of Oncology

基　　金：国家自然科学基金资助项目(39970322);教育部跨世纪人才培养计划基金资助项目

摘　　要：目的探讨T淋巴细胞白血病不同细胞株的混合抗原肽诱导特异性抗瘤免疫的作用及不同细胞株混合抗原肽之间的交叉反应性。方法从不同白血病细胞株中分别制备混合抗原肽,与Hsp70体外结合,观察Hsp70-抗原肽复合物对人外周血单个核细胞(PBMC)的激活增殖作用;以激活增殖的PBMC为效应细胞,对不同的靶细胞进行体外杀伤试验。结果不同白血病细胞株的抗原肽为混合肽,经Hsp70提呈均能够有效激活PBMC,并能使激活的PBMC增殖,增殖活化的PBMC可以特异性杀伤与抗原肽对应的白血病细胞;Hut78-肽和Molt-4-肽激活的PBMC对Hut78细胞、Molt-4细胞和Jurkat细胞的细胞毒作用均显著高于HL-60-肽激活的PBMC(P<0.05)。而Hut78/Molt-4-肽激活的PBMC对Jurkat细胞的杀伤作用则显著高于Hut78-肽和Molt-4-肽单独激活的PBMC(P<0.05)。结论不同T淋巴细胞白血病细胞株来源的混合抗原肽均能够诱导特异性抗肿瘤免疫,其所含的抗原肽之间存在交叉性,通过多株来源的抗原肽混合,这种交叉性可以被放大。Objective To investigate the specific antitumor immunity induced by antigen peptide mixture prepared from different T lymphocytic leukaemia cells and the cross-reaction among the mixtures of different cell lines. Methods Antigen peptide mixtures were prepared from different leukaemia cell lines and then bound with Hsp70 in vitro. The activation and proliferation of peripheral blood mononeuclear cell (PBMC) were observed after the stimulation by different Hsp70-peptide complexes. The cytotoxicity of such activated PBMCs to different target cells was assayed. Results The antigen peptides from different leukaemia cell lines were mixed ones, which could activate PBMC effectively with Hsp70 and stimulate the activated PBMC to proliferate. The proliferative PBMC had specific cytotoxicity to the corresponding leukaemia cells. To Hut-78 cell, Molt-4 cell and Jurkat cell, the cytotoxicity of PBMC activated by either Hut78-peptides or Molt-4-peptides was significantly stronger than that of PBMC activated by HL60-peptides ( P < 0.05). The cytotoxicity to Jurkat cell of PBMC activated by Hut78/Molt-4-peptides was significantly stronger than that of PBMC activated by Hut78-peptides or Molt-4-peptides alone ( P < 0.05). Conclusion Antigen peptide mixture from T lymphocytic leukaemia cells is able to induce specific antitumor immunity. There is a cross-reactivity among antigen peptide mixtures from different T lymphocytic leukaemia cell lines, with the more crossed antigen peptides obtained from the mixtures of different antigen peptides from different T lymphocytic leukaemia cell lines, which suggests that the antigen peptide mixture with broad antigenic spectrum could possibly be prepared by using multiple leukaemia cell lines.

关 键 词：T淋巴细胞白血病 混合抗原肽 细胞毒效应 交叉反应性 

分 类 号：R733.7[医药卫生—肿瘤] R730.51[医药卫生—临床医学]